In vitro and in vivo activities of SCE-2787, a new parenteral cephalosporin with a broad antibacterial spectrum
about
A functional classification scheme for beta-lactamases and its correlation with molecular structureComparative pharmacokinetics of SCE-2787 and related antibiotics in experimental animals.In vivo antibacterial activity of S-3578, a new broad-spectrum cephalosporin: methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa experimental infection models.Pharmacokinetics of cefozopran by single and multiple intravenous infusions in healthy Chinese volunteersTherapeutic effect of cefozopran (SCE-2787), a new parenteral cephalosporin, against experimental infections in miceComparative pharmacokinetics and serum bactericidal activities of SCE-2787 and ceftazidime.In vitro activity of SCE-2787, a new cephalosporin with potent activity against Pseudomonas aeruginosa and members of the family Enterobacteriaceae.Outer membrane proteins responsible for multiple drug resistance in Pseudomonas aeruginosa.TOC-39, a novel parenteral broad-spectrum cephalosporin with excellent activity against methicillin-resistant Staphylococcus aureusIn vitro antibacterial properties of T-5575 and T-5578 novel parenteral 2-carboxypenams.Quantitative correlation between susceptibility and OprJ production in NfxB mutants of Pseudomonas aeruginosa.Comparative analysis of the pathogenicity between multidrug-resistant clinical isolates: isolation of highly pathogenic multidrug-resistant and experimental therapeutics with fourth-generation cephalosporin cefozopran
P2860
Q24677460-F86C82F8-AE3D-47F0-BE88-09FDB799AA15Q33745624-1C39D4EF-764D-4878-9A4B-9ED486FDA953Q35166038-F775DDB3-A2D8-4BFD-A1F7-61101342C0A1Q35175913-558C430A-6A3C-4194-90CD-A4F758F6B349Q35807749-48AF893D-EDB3-46D8-AD69-2A5B79FE3ED1Q35819061-4E18E157-46D8-4C1E-B434-141637EBBCB3Q35823389-3D25EC61-8C3A-431A-B5F8-53B15221B011Q39779320-92B11769-0E37-4C03-B49D-2AA585825328Q39779720-27527D01-3E74-4FAA-978A-9075B82621B0Q39781064-D4805EA9-6640-4F67-BC86-EDEB4D86A57FQ39781815-72CEE79A-78DF-4BE0-8774-B196DC8C741CQ57816201-33EBDAF6-D7FD-4ED9-BCC6-E76500275C17
P2860
In vitro and in vivo activities of SCE-2787, a new parenteral cephalosporin with a broad antibacterial spectrum
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh-hant
name
In vitro and in vivo activitie ...... a broad antibacterial spectrum
@ast
In vitro and in vivo activitie ...... a broad antibacterial spectrum
@en
type
label
In vitro and in vivo activitie ...... a broad antibacterial spectrum
@ast
In vitro and in vivo activitie ...... a broad antibacterial spectrum
@en
prefLabel
In vitro and in vivo activitie ...... a broad antibacterial spectrum
@ast
In vitro and in vivo activitie ...... a broad antibacterial spectrum
@en
P2093
P2860
P356
P1476
In vitro and in vivo activitie ...... a broad antibacterial spectrum
@en
P2093
Yamazaki T
P2860
P304
P356
10.1128/AAC.36.7.1358
P407
P577
1992-07-01T00:00:00Z